Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Nalmefene . HCl

Opioid receptor inhibitor
BML-NO110-0500 500 mg 364.00 USD
Do you need bulk/larger quantities?
Opioid receptor antagonist similar to naloxone but with a slower onset and longer duration of action. Antagonizes the effects of salvinorin (κ-agonist) as well as herkinorin (µ-agonist). A promising drug for the treatment of alcohol dependence.

Product Specification

Alternative Name:(5α)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylene-morphinan-3,14-diol
Formula:C21H25NO3 . HCl
MW:339.4 . 36.5
Purity:≥99% (TLC)
Appearance:White solid.
Solubility:Soluble in water (>25mg/ml).
Long Term Storage:Ambient
Use/Stability:Store solutions at -20°C for up to 3 months.
Please mouse over

Product Literature References

In vivo characterization of the opioid antagonist nalmefene in mice: M.D. Osborn, et al.; Life Sci. 86, 624 (2010), Abstract;
Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid: E.R. Butelman, et al.; J. Pharmacol. Exp. Ther. 328, 588 (2009), Abstract;
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review: M. Soyka & S. Rosner; Curr. Drug Abuse Rev. 1, 280 (2008), Abstract;
The effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primates: E.R. Butelman, et al.; J. Pharmacol. Exp. Ther. 327, 154 (2008), Abstract;

Related Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,